These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21278557)

  • 41. Statins, cardiovascular disease, and drug safety.
    Gotto AM
    Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase.
    Kwok JM; Ma CC; Ma S
    Vascul Pharmacol; 2013 Jan; 58(1-2):21-30. PubMed ID: 23085091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statins--a cure-all for the brain?
    Menge T; Hartung HP; Stüve O
    Nat Rev Neurosci; 2005 Apr; 6(4):325-31. PubMed ID: 15803163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Statin Therapy in Hemorrhagic Stroke.
    Sikora Newsome A; Casciere BC; Jordan JD; Rhoney DH; Sullivan KA; Morbitzer KA; Moore JD; Durr EA
    Pharmacotherapy; 2015 Dec; 35(12):1152-63. PubMed ID: 26684555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin therapy in cardiovascular diseases other than atherosclerosis.
    Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
    Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Statins and asthma].
    Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pleiotropic activity of 3-hydroxy-3-methyl-glutharyl-coenzyme a inhibitors (statins). therapeutic potential in connective tissue diseases ].
    Kotyla PJ
    Ann Acad Med Stetin; 2014; 60(1):39-45; discussion 45-6. PubMed ID: 25518091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases.
    Calabro P; Yeh ET
    Curr Atheroscler Rep; 2004 Jan; 6(1):36-41. PubMed ID: 14662106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins as anti-inflammatory agents.
    Weitz-Schmidt G
    Trends Pharmacol Sci; 2002 Oct; 23(10):482-6. PubMed ID: 12368073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statins and biomarkers of inflammation.
    Devaraj S; Rogers J; Jialal I
    Curr Atheroscler Rep; 2007 Jan; 9(1):33-41. PubMed ID: 17169243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins and myotoxicity.
    Farmer JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):96-100. PubMed ID: 12573193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.
    Epstein M; Campese VM
    Am J Kidney Dis; 2005 Jan; 45(1):2-14. PubMed ID: 15696439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid-lowering therapy. New and established agents reduce risk of cardiovascular events.
    Smith CR
    Postgrad Med; 2004 Mar; 115(3):29-30, 33-6. PubMed ID: 15038253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins in Stroke Prevention: Present and Future.
    Castilla-Guerra L; Del Carmen Fernandez-Moreno M; Colmenero-Camacho MA
    Curr Pharm Des; 2016; 22(30):4638-4644. PubMed ID: 27160755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of statins on toll-like receptors: a new insight to pleiotropic effects.
    Bahrami A; Parsamanesh N; Atkin SL; Banach M; Sahebkar A
    Pharmacol Res; 2018 Sep; 135():230-238. PubMed ID: 30120976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pleiotropic effects of statins: moving beyond cholesterol control.
    Garcia PJ
    Curr Atheroscler Rep; 2005 Feb; 7(1):34-9. PubMed ID: 15683600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The therapeutic potential of statins in neurological disorders.
    Rajanikant GK; Zemke D; Kassab M; Majid A
    Curr Med Chem; 2007; 14(1):103-12. PubMed ID: 17266571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.
    Kim G; Kang ES
    Semin Liver Dis; 2019 May; 39(2):141-152. PubMed ID: 30912095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms underlying the effects of statins in the central nervous system.
    McFarland AJ; Anoopkumar-Dukie S; Arora DS; Grant GD; McDermott CM; Perkins AV; Davey AK
    Int J Mol Sci; 2014 Nov; 15(11):20607-37. PubMed ID: 25391045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.